We are live on
!
Find out more
OAG
Oakmont Advisory Group Portfolio holdings
AUM
$119M
This Fund
S&P 500
This Quarter
Est. Return
+11.54%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$20.9M
(+21%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
10.46%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
513
New
390
Increased
74
Reduced
36
Closed
8
Avg Time Held
0.4
quarters
Top 10 Avg Time Held
1.8
quarters
Top 20 Avg Time Held
1.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest US Equity Buffer ETF March
FMAR
|
+$857K |
| 2 |
FT Vest US Equity Buffer ETF May
FMAY
|
+$855K |
| 3 |
FT Vest US Equity Buffer ETF April
FAPR
|
+$836K |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$774K |
| 5 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$700K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest US Equity Buffer ETF November
FNOV
|
+$747K |
| 2 |
FT Vest US Equity Buffer ETF January
FJAN
|
+$746K |
| 3 |
FT Vest US Equity Buffer ETF December
FDEC
|
+$745K |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$578K |
| 5 |
Hims & Hers Health
HIMS
|
+$564K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.33% |
| 2 | Technology | 5.39% |
| 3 | Healthcare | 4.59% |
| 4 | Consumer Staples | 2.56% |
| 5 | Consumer Discretionary | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Insulet
PODD
$9.13B
| $393K | 0.33% |
2,583
+1,058
| +69% | +$176K |
2025 Q4
2 quarters
|
|
77
Vanguard International Dividend Appreciation ETF
VIGI
$8.84B
| $392K | 0.33% |
4,194
+695
| +20% | +$64.4K |
2025 Q4
2 quarters
|
|
78
Elanco Animal Health
ELAN
$11.1B
| $388K | 0.33% |
15,758
+2,454
| +18% | +$56.7K |
2025 Q4
2 quarters
|
|
79
Halozyme
HALO
$12.5B
| $388K | 0.33% |
4,953
+54
| +1% | +$3.68K |
2026 Q1
1 quarter
|
|
80
Merck
MRK
$356B
| $386K | 0.32% |
3,005
+158
| +6% | +$18.5K |
2025 Q4
2 quarters
|
|
81
United Therapeutics
UTHR
$23.2B
| $379K | 0.32% |
700
+20
| +3% | +$11.3K |
2025 Q4
2 quarters
|
|
82
State Street Consumer Staples Select Sector SPDR ETF
XLP
$13.7B
| $379K | 0.32% |
4,562
-5,714
| -56% | -$477K |
2025 Q4
2 quarters
|
|
83
Kimberly-Clark
KMB
$31.4B
| $375K | 0.32% |
3,419
+425
| +14% | +$42.1K |
2025 Q4
2 quarters
|
|
84
Snap-on
SNA
$19.1B
| $374K | 0.31% |
928
+35
| +4% | +$13.2K |
2025 Q4
2 quarters
|
|
85
Illinois Tool Works
ITW
$74.9B
| $368K | 0.31% |
1,361
+173
| +15% | +$44.9K |
2025 Q4
2 quarters
|
|
86
Procter & Gamble
PG
$337B
| $365K | 0.31% |
2,490
+304
| +14% | +$44.2K |
2025 Q4
2 quarters
|
|
87
Progressive
PGR
$122B
| $363K | 0.3% |
+1,660
| New | +$335K |
2026 Q2
0 quarters
|
|
88
Meta Platforms (Facebook)
META
$1.85T
| $359K | 0.3% |
+638
| New | +$390K |
2026 Q2
0 quarters
|
|
89
T. Rowe Price
TROW
$22.3B
| $358K | 0.3% |
3,151
-366
| -10% | -$37.4K |
2025 Q4
2 quarters
|
|
90
Altria Group
MO
$112B
| $357K | 0.3% |
4,966
-39
| -0.8% | -$2.72K |
2025 Q4
2 quarters
|
|
91
Zoom
ZM
$27.1B
| $356K | 0.3% |
4,120
-943
| -19% | -$89.1K |
2025 Q4
2 quarters
|
|
92
Tesla
TSLA
$1.46T
| $354K | 0.3% |
842
+1
| +0.1% | +$398 |
2025 Q4
2 quarters
|
|
93
Colgate-Palmolive
CL
$67.2B
| $352K | 0.3% |
3,844
+342
| +10% | +$29.9K |
2025 Q4
2 quarters
|
|
94
A.O. Smith
AOS
$7.71B
| $352K | 0.3% |
5,617
+1,342
| +31% | +$81.3K |
2026 Q1
1 quarter
|
|
95
Universal Health Services
UHS
$10.4B
| $350K | 0.29% |
+2,351
| New | +$382K |
2026 Q2
0 quarters
|
|
96
Toast
TOST
$17.2B
| $349K | 0.29% |
12,537
+76
| +0.6% | +$1.98K |
2026 Q1
1 quarter
|
|
97
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
| $347K | 0.29% |
3,537
+630
| +22% | +$62.3K |
2025 Q4
2 quarters
|
|
98
Avery Dennison
AVY
$12.9B
| $338K | 0.28% |
2,080
+391
| +23% | +$63.7K |
2025 Q4
2 quarters
|
|
99
Gilead Sciences
GILD
$179B
| $333K | 0.28% |
2,639
+288
| +12% | +$37.9K |
2025 Q4
2 quarters
|
|
100
The Kraft Heinz Company
KHC
$26.3B
| $331K | 0.28% |
14,023
+984
| +8% | +$22.7K |
2025 Q4
2 quarters
|
|
Similar funds
BCM
FA
DFC
VIP
RMF
AA
AW
BAM
Oakmont Advisory Group's Q2 2026 Portfolio in Review
As of Q2 2026, Oakmont Advisory Group held 513 positions worth $119M, up 21% from $98.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Oakmont Advisory Group deployed $12.5M of net new capital in Q2 2026, opening 390 new positions and adding to 74 existing holdings. Its largest new stake was FT Vest US Equity Buffer ETF March: 16,676 shares worth $871K.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 81% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Hims & Hers Health, an estimated $564K trimmed.
- Oakmont Advisory Group's largest Q2 2026 buy was FT Vest US Equity Buffer ETF March: 16,676 shares worth $871K.
- Oakmont Advisory Group added most to iShares Ultra Short Duration Bond Active ETF in Q2 2026, an estimated $774K increase.
- Oakmont Advisory Group's biggest Q2 2026 reduction was Hims & Hers Health, cutting an estimated $564K.
- Oakmont Advisory Group fully exited FT Vest US Equity Buffer ETF November in Q2 2026, selling an estimated $747K.
- Oakmont Advisory Group's ten largest holdings make up 40% of its $119M portfolio in Q2 2026.
- Oakmont Advisory Group opened 390 new positions and closed 8 in Q2 2026.
- Oakmont Advisory Group's portfolio value rose 21% quarter-over-quarter to $119M.
Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.